Cardiovascular gene therapy: more activity, more diseases, more optimism

Article Abstract:

The article presents the ramifications of gene therapy. Gene augmentation is the utilization of gene therapy to produce therapeutic proteins or to produce gene products which inhibit transcripts (genetic antisense) to treat acquired diseases such as cardiovascular, cancer infections and neurological diseases.

Research and Testing Services, Heart & Cardiovascular R&D, Cardiovascular research

---

Molecular medicine: we will see breakthroughs this decade

Article Abstract:

Methods for causing a gene to generate a drug in the body could result in a major financial saving in therapy. The generation of antisense or antibody fragments would also provide a financially acceptable solution.

---

Antisense: fulfilled promise is close at hand

Article Abstract:

Antisense-based therapies have potential advantages over gene therapy.The safety issues associated with viral vectors can be avoided with antisense.

Similar abstracts:

• Abstracts: Renovascular hypertension. Peripheral arterial disease of the lower extremity. Aortic dissection
• Abstracts: Predicting the unpredictable. Street scenes. The running of the bulls; in which the raging stock market transforms health care
• Abstracts: Survival depends on effective partnerships with suppliers, management, and physicians. Tomorrow's materiel management executive today
• Abstracts: The value of health insurance: the access motive. Health utility indices and equity considerations. Time preference, the discounted utility model and health
• Abstracts: Trial tribulations. Generation hex: most management service companies are young, merging like mad - and losing money

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.